Primary Progressive Multiple Sclerosis

Nonfiction, Health & Well Being, Medical, Allied Health Services, Radiological & Ultrasound, Specialties, Internal Medicine, Neurology
Cover of the book Primary Progressive Multiple Sclerosis by , Springer Milan
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9788847022348
Publisher: Springer Milan Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9788847022348
Publisher: Springer Milan
Publication: December 6, 2012
Imprint: Springer
Language: English

"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin­ ical trials have excluded PPMS patients on two counts. Clinical worsening devel­ ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi­ ence suggests that the results may not be dramatic.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin­ ical trials have excluded PPMS patients on two counts. Clinical worsening devel­ ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi­ ence suggests that the results may not be dramatic.

More books from Springer Milan

Cover of the book Endoscopic Follow-up of Digestive Anastomosis by
Cover of the book The Theory of Evolution and Its Impact by
Cover of the book Anaesthesia, Pharmacology, Intensive Care and Emergency A.P.I.C.E. by
Cover of the book Mechanisms and Management of COPD Exacerbations by
Cover of the book Dawn and Evolution of Cardiac Procedures by
Cover of the book Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E. by
Cover of the book Magnetic Resonance Cholangiopancreatography (MRCP) by
Cover of the book Innovation in Esophageal Surgery by
Cover of the book Primary, Secondary and Tertiary Hyperparathyroidism by
Cover of the book HCV Infection and Cryoglobulinemia by
Cover of the book Management of Gender Dysphoria by
Cover of the book Atlas of Enteroscopy by
Cover of the book Pathways Through Applied and Computational Physics by
Cover of the book Knee Ligament Injuries by
Cover of the book Cone Beam CT and 3D imaging by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy